Rat Group IIA Secreted Phospholipase A

Adrijan Ivanušec, Jernej Šribar, Adrijana Leonardi, Maja Zorović, Marko Živin, Igor Križaj

Open access · goldAbstract read

In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 38% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

Varespladib attenuatesRedox report : communications in free radical research · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Adrijan IvanušecDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.ORCID 0000-0003-4360-9193

Jernej ŠribarDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.ORCID 0000-0003-0646-5602

Adrijana LeonardiDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-9854-9955

Maja ZorovićBrain Research Laboratory, Institute of Pathophysiology, Medical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-3724-8101

Marko ŽivinBrain Research Laboratory, Institute of Pathophysiology, Medical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Igor KrižajDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.ORCID 0000-0003-0203-0708

Jožef Stefan Institute · SIUniversity of Ljubljana · SI

Funding

Slovenian Research Agency P1-0207, P3-0171, 1000-17-0106-6

6 · The paper itself

Abstract

Alzheimer's disease (AD), a progressive form of dementia, is characterized by the increased expression of secreted phospholipase A

Indexed as

Alzheimer DiseaseNeurotoxicity SyndromesPhospholipases A2, SecretoryAnimalsElectron Transport Complex IVMammalsNeuronsPC12 CellsRatsElectron Transport Complex IVPhospholipases A2, SecretoryAlzheimer’s diseaseammodytoxingroup IIA secreted phospholipase A2mitochondrionreceptorsnake venomVipera ammodytesβ-neurotoxicity

Identifiers

PMID36293221

DOI10.3390/ijms232012368

PMCPMC9604285

OpenAlexW4306385526

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.